Renal vascular transit time and tubular transit time dispersion for Tc-99(m)-MAG3

被引:4
|
作者
Russell, CD [1 ]
Japanwalla, M [1 ]
Khan, S [1 ]
Scott, JW [1 ]
Dubovsky, EV [1 ]
机构
[1] UNIV ALABAMA HOSP & CLIN, BIRMINGHAM, AL USA
关键词
D O I
10.1097/00006231-199709000-00006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Renal transit time usually refers to tubular transit time, as introduced by Taplin, but other measures of renal transit have been proposed. Here we examine the vascular transit time (VIT; following Rutlandi and the standard deviation of tubular transit time (SDTT, following Britton) in a group of 30 patients having baseline and ACE-inhibitor Tc-99(m)-MAG3 renography prior to arteriography. A same-day low-dose/high-dose protocol was used for renography; only the post-captopril dose was high enough to measure VTT. Pre-captoyril, the Spearman rank correlation coefficient for SDTT was rho = 0.52 (n = 53 kidneys; P< 0.0002); post-captopril, rho = 0.54 (n = 49 kidneys; P < 0.0002), For VTT, the post-captopril value was rho = 0.24 (n = 30 kidneys; N.S.). For comparison, the same statistics were calculated fur Taplin's original measure of transit time: the time from injection to maximum count rate (peak time). Precaptopril, for peak time, rho was 0.47 (n = 53 kidneys; P < 0.001); post-captopril, rho was 0.39 (n = 50 kidneys, P < 0.01). These findings confirm the diagnostic value of SDTT but not of VTT. SDTT correlated better than peak time with the arteriographic findings.
引用
收藏
页码:832 / 838
页数:7
相关论文
共 50 条
  • [1] TC-99(3) MAG3 - A NEW RENAL RADIOPHARMACEUTICAL
    BRITTON, KE
    JAFRI, RA
    ALNAHAS, AA
    BOMANJI, J
    SOLANKI, K
    NIMMON, CC
    BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (727): : 655 - 655
  • [2] A FURTHER APPLICATION OF TC-99(M)-MAG3 IN CHILDREN
    CHAPMAN, S
    MOUNTFORD, PJ
    BOIVIN, CM
    BURRELL, DN
    NUCLEAR MEDICINE COMMUNICATIONS, 1992, 13 (12) : 897 - 898
  • [3] Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient
    Murthy, Rajan
    Chahal, Manisha
    Appel, Gerald
    Bergmann, Steven
    Tikofsky, Ronald
    Fawwaz, Rashid
    Van Heertum, Ronald
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (12) : 829 - 834
  • [4] Tc-99(m)-MAG3: A sensitive indicator for evaluating perfusion and rejection of renal transplants
    Oriuchi, N
    Miyamoto, K
    Hoshino, K
    Imai, J
    Takahashi, Y
    Sakai, S
    Shimada, A
    Endo, K
    NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (05) : 400 - 404
  • [5] Tc-99(m)-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: A comparative study with Tc-99(m)-MAG3
    Kibar, M
    Noyan, A
    Anarat, A
    NUCLEAR MEDICINE COMMUNICATIONS, 1997, 18 (01) : 44 - 52
  • [6] Comparison between Tc-99 m DTPA and Tc-99 m MAG3 Renal Scintigraphy for Prediction of Early Adverse Outcome After Kidney Transplantation
    Daris Theerakulpisut
    Bandit Thinkhamrop
    Sirirat Anutrakulchai
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 302 - 310
  • [7] Comparison between Tc-99 m DTPA and Tc-99 m MAG3 Renal Scintigraphy for Prediction of Early Adverse Outcome After Kidney Transplantation
    Theerakulpisut, Daris
    Thinkhamrop, Bandit
    Anutrakulchai, Sirirat
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (06) : 302 - 310
  • [8] MEASUREMENT OF RENAL PARENCHYMAL TRANSIT-TIME OF TC-99M-MAG3 USING FACTOR-ANALYSIS
    RUSSELL, CD
    YESTER, MV
    DUBOVSKY, EV
    NUKLEARMEDIZIN, 1990, 29 (04) : 170 - 176
  • [9] TC-99M MAG3 - A ROUTINE RENAL RADIOPHARMACEUTICAL
    BRITTON, KE
    ALNAHHAS, AA
    JAFRI, RA
    BOMANJI, J
    SOLANKI, K
    CARROLL, MJ
    NIMMON, CC
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (04) : AB1 - AB2
  • [10] (TC-99(M))MAG3 GAMMA-CAMERA NEPHROGRAPHY IN EPIDEMIC NEPHRITIS
    PAUL, R
    KIILIAINEN, H
    TARSSANEN, L
    VORNE, M
    NUCLEAR MEDICINE COMMUNICATIONS, 1991, 12 (01) : 15 - 25